Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rationale and Design of Ferric Polymaltose Hydroxide and Iron Sucrose Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study

NCT04225728 is registered in ClinicalTrials.gov with CN NGANOU-GNINDJIO, MD, MSc as lead sponsor.

NCT NCT04225728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04225728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rationale and Design of Ferric Polymaltose Hydroxide and Iron Sucrose Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study
Lead sponsor
CN NGANOU-GNINDJIO, MD, MSc
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2017
Completion date
June 1, 2018
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure (chf), iron deficiency